Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Vaxess Technologies logo — Forging a path to more convenient, self-empowered, and acces...

Vaxess Technologies

Forging a path to more convenient, self-empowered, and accessible healthcare

Founded 2012 United States Boston, United States 61 employees Series Unknown Total: $83.24M Biotechnology, Health Care

General Information

Company Name Vaxess Technologies
Founded Year 2012
Location United States Boston, United States +1
Employees 61
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Vaxess Technologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vaxess Technologies

Vaxess Technologies, established in 2012, is positioning itself as a transformative force in the Biotechnology and Health Care industries. The company is dedicated to making healthcare more convenient, self-empowered, and accessible through its innovative delivery platform.

The platform features a proprietary microarray patch and applicator, which allows for precise dose delivery of advanced therapies without the need for refrigeration. This approach not only enhances convenience but also extends the reach of critical healthcare delivery to low-resource settings.

To date, Vaxess Technologies has secured over $100 million in funding from prominent investors such as RA Capital Management, Engine Ventures, GHIC, Mission BioCapital, and notable funding bodies like BARDA, DARPA, NIH, NSF, and the Gates Foundation. Their latest financing achievement includes a $12.00 million Venture Round investment on May 22, 2024.

Taxonomy: Microarray Patch Technology, Sustained Release Vaccines, Next-Generation Therapies, Dose Delivery Control, Non-Refrigerated Delivery, Low-Resource Settings Delivery, Therapeutic Patch Platforms, Biomaterials Innovation, Immune Response Enhancement, Venture Capital Funding, Clinical Proof of Concept, In-vivo Efficacy, Stability Engineered Solutions, Grant Funding from Health Agencies, Payload Customization

Services & Products

Development of microarray patch platforms
Delivery of next-gen therapies using MAP
Temperature stable drug delivery solutions

Target Customers

Patients seeking convenient healthcare solutions Individuals needing temperature stable treatments Healthcare providers looking for innovative delivery methods

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $12.00M 4
RA Capital Management Global Health Investment Corporation Mission BioCapital Engine Ventures
22 May 2024
Venture Round $9.00M 4
Ulu Ventures RA Capital Management The Engine Global Health Investment Corporation
13 Sep 2023
Series B $10.00M 3
RA Capital Management The Engine Mission BioCapital
10 Jan 2023
Series B $27.00M 4
RA Capital Management The Engine Global Health Investment Corporation Mission BioCapital
02 Nov 2022
Series A $8.20M 3
The Engine Mission BioCapital BioInnovation
27 Jun 2019

View All 15 Funding Rounds

Vaxess Technologies Alternatives & Competitors

Vaxess Technologies vs
Medherant Limited
Medherant Limited United Kingdom

Medherant develops drug delivery products for pain and CNS diseases using its proprietary TEPI Patch...

Unknown
17 employees
Compare Vaxess Technologies vs Medherant Limited
Vaxess Technologies vs
Archimedes Pharma
Archimedes Pharma United Kingdom

Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitati...

Acquired
30 employees
Biotechnology, Health Care
Compare Vaxess Technologies vs Archimedes Pharma
Vaxess Technologies vs
Business Capital Providers, Inc.
Business Capital Providers, Inc. United States

Funding Americas Small Businesses

4 employees
Financial Services
Compare Vaxess Technologies vs Business Capital Providers, Inc.

FAQ About Vaxess Technologies

Forging a path to more convenient, self-empowered, and accessible healthcare
Vaxess Technologies was founded in 2012.
Vaxess Technologies is headquartered in Boston, United States.
Vaxess Technologies operates in the following industries: Biotechnology, Health Care.
Vaxess Technologies has approximately 61 employees.
Vaxess Technologies has completed 15 funding rounds, raising a total of $83.24M. The latest funding stage is Series Unknown.
Vaxess Technologies offers: Development of microarray patch platforms, Delivery of next-gen therapies using MAP, Temperature stable drug delivery solutions.
Top alternatives and competitors to Vaxess Technologies include Medherant Limited, Archimedes Pharma, Business Capital Providers, Inc., Micrel Medical Devices, HipLogic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaxess Technologies and Medherant Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vaxess Technologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy